Learn more about our views and our practices across a range of issues that are important to GSK, our patients and our stakeholders.

The GSK Code sets out the commitments GSK and our people make to get ahead together – so we can deliver on our ambition in the right way, bring our culture to life and make GSK an exciting and inspiring place to work.

As detailed in our Code of Conduct, we do not tolerate harassment, unwelcome, unreasonable or offensive behaviour or discrimination of any kind. Our Equal and Inclusive Treatment policy is designed to help our employees and complementary workers understand their role in ensuring GSK is a company where all employees are treated equally.

The Anti-Bribery and Corruption (ABAC) Programme is part of GSK’s response to the threat and risk of bribery and corruption. The programme includes an ABAC Policy and Standard, which have been designed to help staff and external parties understand bribery and corruption risk, and their responsibilities to actively combat it.

Our annual Modern Slavery Act statement, as required by the Modern Slavery Act 2015 (“the Act”), provides details on the controls we have adopted to ensure that modern slavery and human trafficking do not take place in our supply chain or in any part of our business. The statement covers our financial year which runs from 1 January to 31 December.

Our Third Party Oversight Programme helps control risks from third party business engagements with suppliers, distributors and other business partners. We want to work with business partners who share our commitment of high ethical standards and operating in a responsible way.

In Australia, we conduct our work according to the Medicines Australia Code of Conduct.

The Code sets the standards for the ethical marketing and promotion of prescription pharmaceutical products in Australia.

Read more about the MA Code of Conduct